meclofenamic acid has been researched along with Tachycardia, Ventricular in 2 studies
Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cardiac arrhythmias are a major factor in the occurrence of morbidity and sudden death in patients with cardiovascular disease." | 1.72 | TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias. ( Hendrikx, L; Jacobs, G; Kecskés, M; Kerselaers, S; Lehnart, SE; Nilius, B; Oosterlinck, W; Philippaert, K; Pinto, S; Pironet, A; Priori, SG; Segal, A; Van Den Broeck, E; Vandewiele, F; Vennekens, R; Verelst, J; Voets, T; Wegener, J, 2022) |
| "The incidence of ventricular tachycardia was reduced from 75% to 25% (P<0." | 1.30 | Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion. ( György, K; Papp, JG; Parratt, JR; Rastegar, MA; Végh, A, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vandewiele, F | 1 |
| Pironet, A | 1 |
| Jacobs, G | 1 |
| Kecskés, M | 1 |
| Wegener, J | 1 |
| Kerselaers, S | 1 |
| Hendrikx, L | 1 |
| Verelst, J | 1 |
| Philippaert, K | 1 |
| Oosterlinck, W | 1 |
| Segal, A | 1 |
| Van Den Broeck, E | 1 |
| Pinto, S | 1 |
| Priori, SG | 1 |
| Lehnart, SE | 1 |
| Nilius, B | 1 |
| Voets, T | 1 |
| Vennekens, R | 1 |
| Végh, A | 1 |
| György, K | 1 |
| Rastegar, MA | 1 |
| Papp, JG | 1 |
| Parratt, JR | 1 |
2 other studies available for meclofenamic acid and Tachycardia, Ventricular
| Article | Year |
|---|---|
TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Meclofenamic Acid; Mice; Myocytes, Cardiac; Tachycardia, Ven | 2022 |
Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Coronary Vessels | 1999 |